通过先进的超脂血症管理工具减少电子健康记录的导航时间 工具:对效率的评估
Chin-Chen Chen1, Yu-Chen Liu2, Guan-Ling Lin3
1Information Technology Department, Cardinal Tien Hospital, New Taipei City, Taiwan; Information Technology Department, Yonghe Cardinal Tien Hospital, New Taipei City, Taiwan; Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
International journal of medical informatics
|June 20, 2025
概括
一个新的高脂血症药物提醒系统 (HLD-MRS) 显著减少了电子健康记录导航时间,并改善了对高脂血症护理的患者监测. 该系统提高了繁忙的门诊机构的效率.
科学领域:
- 心血管医学 心血管医学
- 医疗信息学 医疗信息学
- 临床决策支持系统 临床决策支持系统
背景情况:
- 有效的高脂血症管理对于预防心血管疾病至关重要.
- 传统的电子健康记录 (EHR) 系统在有效识别和跟踪高脂血症风险患者方面存在挑战.
- 简化EHR导航对于改善患者护理工作流程至关重要.
研究的目的:
- 评估高脂血症药物提醒系统 (HLD-MRS) 对EHR导航效率的影响.
- 评估该系统在加强超脂血症患者跟踪和管理方面的有效性.
- 为了确定系统在地区医院环境中的实用性.
主要方法:
- 使用了前后前性研究设计.
- 开发HLD-MRS的目的是将患者数据,临床指南和风险评估整合到一个统一的界面中.
- 在多个部门实施 HLD-MRS 之前和之后,比较了 EHR 导航时间和患者监测率.
主要成果:
- HLD-MRS的实施使平均EHR导航时间从83.9s大幅减少到53.8s (p < 0.001).
- 积极监测的高脂血症患者的比例从42.5%增加到56.6%.
- 未知或被扣留评估状态的比例从57.5%大幅下降到28.4%.
结论:
- HLD-MRS显然提高了EHR导航效率,并增加了对高脂血症的积极患者监测.
- 这种指导方针驱动的决策支持工具显示出在大量门诊环境中优化超脂血症护理的巨大潜力.
- 该系统提供了一个有前途的解决方案,用于提高临床工作流程和患者在管理高脂血症的结果.
相关概念视频
01:26Atherosclerosis III: Management
42
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
42
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
890
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
890
01:20Angina V: Nursing Management
56
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
56
01:26Angina IV: Management
31
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
31
01:27Peripheral Artery Disease III: Interprofessional Care
34
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
34
01:30Heart Failure V: Medical Management
34
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
34